Andrew J. Last - Sep 1, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Operating Officer
Signature
/s/ Andrew J. Last
Stock symbol
BIO
Transactions as of
Sep 1, 2023
Transactions value $
-$456,552
Form type
4
Date filed
9/6/2023, 03:28 PM
Previous filing
Jun 27, 2023
Next filing
Mar 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +867 +22.85% $0.00 4.66K Sep 1, 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$170K -430 -9.23% $394.60 4.23K Sep 1, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +633 +14.96% $0.00 4.86K Sep 1, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$110K -279 -5.74% $394.60 4.58K Sep 1, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +903 +19.7% $0.00 5.49K Sep 2, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$177K -448 -8.16% $394.60 5.04K Sep 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +5.01K $0.00 5.01K Sep 1, 2023 Bio-Rad A Common Stock 5.01K $0.00 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -867 -24.99% $0.00 2.6K Sep 1, 2023 Bio-Rad A Common Stock 867 $0.00 Direct F3, F5
transaction BIO Restricted Stock Units Options Exercise $0 -633 -33.33% $0.00 1.27K Sep 1, 2023 Bio-Rad A Common Stock 633 $0.00 Direct F3, F6
transaction BIO Restricted Stock Units Options Exercise $0 -903 -50% $0.00 903 Sep 2, 2023 Bio-Rad A Common Stock 903 $0.00 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 26.9850 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.